CD19 and neoplasm: As expected, NCG mice that were adoptively transferred with CAR-T cells that had been expanded in ↑[H+] showed a greater clearance of implanted CD19+ tumor as compared with those that received CAR-T cells that had been expanded in control medium (Fig. 5j).